Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Role of capecitabine in treating metastatic colorectal cancer in Chinese patients.

Wang F, Wang FH, Bai L, Xu RH.

Onco Targets Ther. 2014 Apr 2;7:501-11. doi: 10.2147/OTT.S38843. eCollection 2014. Review.

PMID:
24729715
[PubMed]
Free PMC Article
2.

Capecitabine: a review.

Walko CM, Lindley C.

Clin Ther. 2005 Jan;27(1):23-44. Review.

PMID:
15763604
[PubMed - indexed for MEDLINE]
3.

Efficacy of the oral fluorouracil pro-drug capecitabine in cancer treatment: a review.

Koukourakis GV, Kouloulias V, Koukourakis MJ, Zacharias GA, Zabatis H, Kouvaris J.

Molecules. 2008 Aug 27;13(8):1897-922. Review.

PMID:
18794792
[PubMed - indexed for MEDLINE]
Free Article
4.

Capecitabine for locally advanced and metastatic colorectal cancer: A review.

Koukourakis GV, Zacharias G, Tsalafoutas J, Theodoridis D, Kouloulias V.

World J Gastrointest Oncol. 2010 Aug 15;2(8):311-21. doi: 10.4251/wjgo.v2.i8.311.

PMID:
21160892
[PubMed]
Free PMC Article
5.

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer.

Li YH, Luo HY, Wang FH, Wang ZQ, Qiu MZ, Shi YX, Xiang XJ, Chen XQ, He YJ, Xu RH.

J Cancer Res Clin Oncol. 2010 Apr;136(4):503-10. doi: 10.1007/s00432-009-0682-5. Epub 2009 Sep 24.

PMID:
19777259
[PubMed - indexed for MEDLINE]
6.

Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy.

Koukourakis G, Kouloulias V, Zacharias G, Koukourakis M.

J BUON. 2010 Oct-Dec;15(4):652-9.

PMID:
21229625
[PubMed - indexed for MEDLINE]
7.

A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients.

Van Cutsem E, Verslype C, Beale P, Clarke S, Bugat R, Rakhit A, Fettner SH, Brennscheidt U, Feyereislova A, Delord JP.

Ann Oncol. 2008 Feb;19(2):332-9. Epub 2007 Nov 6.

PMID:
17986625
[PubMed - indexed for MEDLINE]
Free Article
8.

Retrospective analysis of capecitabine and oxaliplatin (XELOX) plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer.

Uchima Y, Nishii T, Iseki Y, Ishii M, Hiramatsu S, Iwauchi T, Morimoto J, Kosaka K, Tei S, Takeuchi K.

Mol Clin Oncol. 2014 Jan;2(1):134-138. Epub 2013 Oct 22.

PMID:
24649322
[PubMed]
Free PMC Article
9.

Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer.

Vrdoljak E, Omrčen T, Boban M, Hrabar A.

Anticancer Drugs. 2011 Feb;22(2):191-7. doi: 10.1097/CAD.0b013e3283417f3e.

PMID:
21057306
[PubMed - indexed for MEDLINE]
10.

Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer.

Grande C, Quintero G, Candamio S, París Bouzas L, Villanueva MJ, Campos B, Gallardo E, Alvarez E, Casal J, Mel JR; Grupo Gallego de Investigaciones Oncológicas (GGIO).

J Geriatr Oncol. 2013 Apr;4(2):114-21. doi: 10.1016/j.jgo.2013.01.001. Epub 2013 Feb 16.

PMID:
24071536
[PubMed - indexed for MEDLINE]
11.
12.

Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study.

Hofheinz RD, Gnad-Vogt U, Wein A, Saussele S, Kreil S, Pilz L, Hehlmann R, Hochhaus A.

Anticancer Drugs. 2005 Jan;16(1):39-45.

PMID:
15613902
[PubMed - indexed for MEDLINE]
13.

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.

Cassidy J, Tabernero J, Twelves C, Brunet R, Butts C, Conroy T, Debraud F, Figer A, Grossmann J, Sawada N, Schöffski P, Sobrero A, Van Cutsem E, Díaz-Rubio E.

J Clin Oncol. 2004 Jun 1;22(11):2084-91.

PMID:
15169795
[PubMed - indexed for MEDLINE]
14.

KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(25):1-49. Epub 2010 Dec 1.

PMID:
23074403
[PubMed]
Free PMC Article
15.

Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group.

Garcia-Alfonso P, Muñoz-Martin A, Mendez-Ureña M, Quiben-Pereira R, Gonzalez-Flores E, Perez-Manga G.

Br J Cancer. 2009 Oct 6;101(7):1039-43. doi: 10.1038/sj.bjc.6605261. Epub 2009 Sep 8.

PMID:
19738605
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Bevacizumab: a review of its use in combination with paclitaxel or capecitabine as first-line therapy for HER2-negative metastatic breast cancer.

Croom KF, Dhillon S.

Drugs. 2011 Nov 12;71(16):2213-29. doi: 10.2165/11207720-000000000-00000. Review.

PMID:
22035518
[PubMed - indexed for MEDLINE]
17.

Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.

Shih T, Lindley C.

Clin Ther. 2006 Nov;28(11):1779-802. Review.

PMID:
17212999
[PubMed - indexed for MEDLINE]
18.

The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer.

Shin SJ, Ahn JB, Choi HJ, Cho BC, Jeung HC, Rha SY, Chung HC, Roh JK.

Cancer Chemother Pharmacol. 2008 Jan;61(1):75-81. Epub 2007 Mar 21.

PMID:
17375304
[PubMed - indexed for MEDLINE]
19.

Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer.

Karacetin D, Yalcin B, Okten B, Ozturk S, Maral O, Incekara O.

J BUON. 2009 Oct-Dec;14(4):605-8.

PMID:
20148449
[PubMed - indexed for MEDLINE]
20.

A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial.

Giessen C, von Weikersthal LF, Hinke A, Stintzing S, Kullmann F, Vehling-Kaiser U, Mayerle J, Bangerter M, Denzlinger C, Sieber M, Teschendorf C, Freiberg-Richter J, Schulz C, Modest DP, Moosmann N, Aubele P, Heinemann V.

BMC Cancer. 2011 Aug 23;11:367. doi: 10.1186/1471-2407-11-367.

PMID:
21861888
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk